Hemolytic Anemia Associated with Dapsone Therapy in Pemphigus Foliaceus: A Case Report
Koppula Sirisha, Rajagiri Triveni, Nalam Vineela Nirmala, Lingineni Mani Deepa Chandrika, Jammu Neelima, Kadiyala Bhuvaneswari & Komara Kiranmai · Asian Hematology Research Journal · 2026
Background: Dapsone is frequently used as a steroid-sparing agent in autoimmune blistering disorders such as pemphigus foliaceus. Although generally well tolerated, dapsone can rarely cause serious hematological adverse effects, including hemolytic anemia, which may be life-threa...